Amrou Sarraj, MD
- Specialty: Neurology
-
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Cleveland Medical Center Bolwell (0 mi.)
11100 Euclid Ave
Bolwell 5th Floor
Cleveland, OH 44106
216-844-3192
Biography: Amrou Sarraj, MD
Titles
- Director, Stroke Systems, Neurological Institute, University Hospitals
- Director, Comprehensive Stroke Center, UH Cleveland Medical Center
- Clinical Professor of Neurology, CWRU School of Medicine
- Professor of Neurology, CWRU School of Medicine
- George M Humphrey II Endowed Chair, CWRU School of Medicine
Certifications & Memberships
- Vascular Neurology - American Board of Psychiatry and Neurology
- Neurology - American Board of Psychiatry and Neurology
Education
Fellowship | Clinical Neurophysiology
Clinical Neurophysiology - University Of Texas Health Science Center At Houston (2011 - 2012)
Fellowship | Vascular Neurology
Vascular Neurology - University Of Texas Health Science Center At Houston (2010 - 2011)
Residency | Neurology
Neurology - University Of Texas Health Science Center At Houston (2007 - 2010)
Internship | Internal Medicine
Internal Medicine - University Of Illinois At Chicago Medical Center (2006 - 2007)
Medical Education
University Of Damascus Faculty Of Medicine (2005)
About
Amrou Sarraj, MD is the Director of the Cerebrovascular Center and Comprehensive Stroke Center at University Hospitals Cleveland Medical Center, Director of Stroke Systems at University Hospitals Neurological Institute, Professor of Neurology at Case Western Reserve University, and George M Humphrey II endowed chair. Dr. Sarraj is an internationally recognized vascular neurologist and clinician scientist with primary interests in endovascular thrombectomy and optimal patient selection. He graduated from Damascus School of Medicine in 2005. After finishing his internship at the University of Illinois Chicago, he completed his residency and fellowship in Vascular Neurology at the University of Texas Health Science Center at Houston in 2012. He held the positions of tenured associate professor of Neurology, director for the Vascular Neurology Fellowship program, the Chief of General Neurology service, and the Vice-chair, Clinical Quality at UTHealth Houston prior to his move to Cleveland.
Dr. Sarraj is the Global Principal Investigator of SELECT 2, a recently completed, groundbreaking international randomized controlled trial that demonstrated efficacy and safety of endovascular thrombectomy in patients with large core strokes. He is the Principal Investigator of the SELECT trial, recently completed a multicenter United States study for imaging selection prior to endovascular thrombectomy. He has also served as the site PI for multiple other clinical trials.
Dr. Sarraj has numerous first and last-author publications in the New England Journal of Medicine, the Lancet, JAMA, JAMA Neurology, Lancet Neurology, Annals of Neurology, Stroke and several other high-impact journals. He presented his research at multiple plenary sessions nationally and internationally and has been awarded the “Mordecai Y. T. Globus New Investigator Award in Stroke” in 2013 and the “Stroke Care in Emergency Medicine Award” in 2020 from American Heart Association/American Stroke Association.
Research & Publications
Research Links
PubMed
View Research
Research Interests
Endovascular thrombectomy: Patient selection optimization strategies, clinical outcomes enhancement, advanced neuroimaging for acute stroke, stroke systems of care and thrombectomy access
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Amrou Sarraj did not disclose any Outside Relationships with Industry.